The PMDA (Pharmaceuticals and Medical Devices Agency) plays a crucial role in Japan’s medical device reimbursement by overseeing regulatory approval. Devices must pass PMDA safety, efficacy, and quality evaluations before reimbursement applications to MHLW and Chuikyo. PMDA’s approval ensures devices meet Japanese standards, enabling inclusion in the NHI reimbursement system.
